NCT05265065 - Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia. | Biotech Hunter

Enrollment

601

Participants

Timeline

Start Date

May 27, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

November 6, 2024

Conditions

COVID-19

Interventions

BIOLOGICAL

Tozinameran - Standard Dose

"Tozinameran is a single-stranded, 5'-capped messenger RNA (mRNA) produced using a cellfree in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).~Dose - 30 µg in 0.3 ml. Liquid for injection. Single dose."

BIOLOGICAL

Tozinameran - Fractional Dose

"Tozinameran is a single-stranded, 5'-capped messenger RNA (mRNA) produced using a cellfree in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).~Dose - 15 µg in 0.15 ml. Liquid for injection. Single dose."

Trial Locations (1)

Unknown

District Health Centre, Ulaanbaatar